0

Close
 
Upcoming Allied Market Research
2023
Animal Health Market

Animal Health Market

by Animal type (Production animal, Companion animal), by Product (Vaccines, Pharmaceutical, Diagnostics, Feed Additives), by Distribution channel (Retail, Veterinary Hospitals Clinics, E-commerce) and by End User (Reference Laboratories, Veterinary Hospitals Clinics, Point-of-care Testing/In-house Testing, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals
Report Code: A05127
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Animal Health Market

Request Now !

Monitoring animal health monitoring and preventing disease outbreaks is one of the important factors for the country’s economy and safety of the food supply across the nation. Thus, the production of healthier livestock ensures a better-quality food supply and keeps the prices stable for the consumers. Animal diseases often devastate the world’s communities as well as disturb the international trade. Prevention and control of animal diseases boosts economies, strengthens local communities, and enhances the overall health of the animal population. 

There has been significant increase in R&D for animal care with the augment in animal population and increase in incidences of diseases in animals. According to a report by American Pet Products Association in 2019, the overall spending on pets and animals approaches USD 70 billion. 

Rise in demand for protein rich foods such as milk, eggs, and meat, increase in adoption of companion animals, growth in population, changes in lifestyle, and surge in per capita income are the factors that drive the growth of the animal health market. Moreover, increase in demand for meat from countries such as China, the U.S., Brazil, and Japan, and the rise in risk of zoonotic diseases—infections that transfer from animals to humans have subsequently contributed toward the growth of the animal health market. However, affordability issues faced by the pet owners and a shift toward vegetarian diet hinder the industry augmentation.

The animal health market is segmented based on by animal type, product, distribution channel, end user, and region. Under the animal type segment, the market is bifurcated into production animal and companion animal. Based on type, the production animal segment is further divided into poultry, cattle, swine, fish, and sheep & goats and based on product, the production animal is classified into vaccines, diagnostics, feed additives, pharmaceuticals, and others. Based on type, the companion animal segment is divided into dogs, horses, cats, and others and based on product, the companion animal segment is fragmented into vaccines, diagnostics, feed additives, pharmaceuticals, and others. Under the product segment, the market is fragmented into vaccines (live attenuated vaccines, inactivated vaccines, recombinant vaccines, DNA vaccines and others), pharmaceuticals (parasiticides, analgesics, anti-inflammatory, anti-infectives and others), feed additives (nutritional and medicinal), and diagnostics (instruments and consumables). The distribution channel segment is categorized into retail, veterinary hospitals & clinics, and e-commerce. The end user segment is divided into reference laboratories, veterinary hospitals & clinics, point-of-care testing/in-house testing, and others. Based on region, the market has been analyzed across North America, Asia-Pacific, Europe, and LAMEA.

Some of the major players operating in the animal health market include Intas Pharmaceuticals, Ltd., Merck Animal Health, Bayer, Sanofi S.A. (MERIAL Limited), Elanco (Eli Lilly and Company), Zydus Animal Health, Zoetis, Inc., Vetoquinol, Ceva Santé Animale, and Virbac Group. The other players operating in the animal health market are C.H. Boehringer Sohn AG & Co. KG, Dechra Pharmaceuticals, Nutreco N.V., and Phirbo Animal Health, Zoetis.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a detailed quantitative analysis of the current market trends and market forecast estimations which assists to identify the prevailing animal health market opportunities. 
  • An in-depth market analysis includes analysis of various regions and is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the global market is provided.
  • Region-wise and country-wise animal health market conditions are comprehensively analyzed in this report.
  • The projections in this report are made by analyzing the current market trends and future market potential in terms of value.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps understand competitive outlook of the global animal health market.  

 Animal Health Market Report Highlights

Aspects Details
By Animal type
  • Production animal
  • Companion animal
By Product
  • Vaccines
  • Pharmaceutical
  • Diagnostics
  • Feed Additives
By Distribution channel
  • Retail
  • Veterinary Hospitals & Clinics
  • E-commerce
By End User
  • Reference Laboratories
  • Veterinary Hospitals & Clinics
  • Point-of-care Testing/In-house Testing
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Zydus Animal Health, Merck Animal Health, Bayer, Zoetis Inc., Virbac Group, Ceva Santé Animale, Elanco (Eli Lilly and Company), Sanofi S.A. (MERIAL Limited), Vetoquinol, Intas Pharmaceuticals Ltd.
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: ANIMAL HEALTH MARKET, BY ANIMAL TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Animal Type

    • 4.2. Production Animal

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Companion Animal

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: ANIMAL HEALTH MARKET, BY PRODUCT

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Product

    • 5.2. Vaccines

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Pharmaceutical

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Diagnostics

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Feed Additives

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: ANIMAL HEALTH MARKET, BY DISTRIBUTION CHANNEL

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Distribution Channel

    • 6.2. Retail

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Veterinary Hospitals Clinics

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. E-commerce

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: ANIMAL HEALTH MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Reference Laboratories

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Veterinary Hospitals Clinics

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Point-of-care Testing/In-house Testing

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

    • 7.5. Others

      • 7.5.1. Key Market Trends, Growth Factors and Opportunities

      • 7.5.2. Market Size and Forecast, By Region

      • 7.5.3. Market Share Analysis, By Country

  • CHAPTER 8: ANIMAL HEALTH MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Animal Type

      • 8.2.3. Market Size and Forecast, By Product

      • 8.2.4. Market Size and Forecast, By Distribution Channel

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Animal Health Market

        • 8.2.7.1. Market Size and Forecast, By Animal Type
        • 8.2.7.2. Market Size and Forecast, By Product
        • 8.2.7.3. Market Size and Forecast, By Distribution Channel
        • 8.2.7.4. Market Size and Forecast, By End User

      • 8.2.8. Canada Animal Health Market

        • 8.2.8.1. Market Size and Forecast, By Animal Type
        • 8.2.8.2. Market Size and Forecast, By Product
        • 8.2.8.3. Market Size and Forecast, By Distribution Channel
        • 8.2.8.4. Market Size and Forecast, By End User

      • 8.2.9. Mexico Animal Health Market

        • 8.2.9.1. Market Size and Forecast, By Animal Type
        • 8.2.9.2. Market Size and Forecast, By Product
        • 8.2.9.3. Market Size and Forecast, By Distribution Channel
        • 8.2.9.4. Market Size and Forecast, By End User

    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Animal Type

      • 8.3.3. Market Size and Forecast, By Product

      • 8.3.4. Market Size and Forecast, By Distribution Channel

      • 8.3.5. Market Size and Forecast, By End User

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Animal Health Market

        • 8.3.7.1. Market Size and Forecast, By Animal Type
        • 8.3.7.2. Market Size and Forecast, By Product
        • 8.3.7.3. Market Size and Forecast, By Distribution Channel
        • 8.3.7.4. Market Size and Forecast, By End User

      • 8.3.8. Germany Animal Health Market

        • 8.3.8.1. Market Size and Forecast, By Animal Type
        • 8.3.8.2. Market Size and Forecast, By Product
        • 8.3.8.3. Market Size and Forecast, By Distribution Channel
        • 8.3.8.4. Market Size and Forecast, By End User

      • 8.3.9. Italy Animal Health Market

        • 8.3.9.1. Market Size and Forecast, By Animal Type
        • 8.3.9.2. Market Size and Forecast, By Product
        • 8.3.9.3. Market Size and Forecast, By Distribution Channel
        • 8.3.9.4. Market Size and Forecast, By End User

      • 8.3.10. Spain Animal Health Market

        • 8.3.10.1. Market Size and Forecast, By Animal Type
        • 8.3.10.2. Market Size and Forecast, By Product
        • 8.3.10.3. Market Size and Forecast, By Distribution Channel
        • 8.3.10.4. Market Size and Forecast, By End User

      • 8.3.11. UK Animal Health Market

        • 8.3.11.1. Market Size and Forecast, By Animal Type
        • 8.3.11.2. Market Size and Forecast, By Product
        • 8.3.11.3. Market Size and Forecast, By Distribution Channel
        • 8.3.11.4. Market Size and Forecast, By End User

      • 8.3.12. Russia Animal Health Market

        • 8.3.12.1. Market Size and Forecast, By Animal Type
        • 8.3.12.2. Market Size and Forecast, By Product
        • 8.3.12.3. Market Size and Forecast, By Distribution Channel
        • 8.3.12.4. Market Size and Forecast, By End User

      • 8.3.13. Rest Of Europe Animal Health Market

        • 8.3.13.1. Market Size and Forecast, By Animal Type
        • 8.3.13.2. Market Size and Forecast, By Product
        • 8.3.13.3. Market Size and Forecast, By Distribution Channel
        • 8.3.13.4. Market Size and Forecast, By End User

    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Animal Type

      • 8.4.3. Market Size and Forecast, By Product

      • 8.4.4. Market Size and Forecast, By Distribution Channel

      • 8.4.5. Market Size and Forecast, By End User

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Animal Health Market

        • 8.4.7.1. Market Size and Forecast, By Animal Type
        • 8.4.7.2. Market Size and Forecast, By Product
        • 8.4.7.3. Market Size and Forecast, By Distribution Channel
        • 8.4.7.4. Market Size and Forecast, By End User

      • 8.4.8. Japan Animal Health Market

        • 8.4.8.1. Market Size and Forecast, By Animal Type
        • 8.4.8.2. Market Size and Forecast, By Product
        • 8.4.8.3. Market Size and Forecast, By Distribution Channel
        • 8.4.8.4. Market Size and Forecast, By End User

      • 8.4.9. India Animal Health Market

        • 8.4.9.1. Market Size and Forecast, By Animal Type
        • 8.4.9.2. Market Size and Forecast, By Product
        • 8.4.9.3. Market Size and Forecast, By Distribution Channel
        • 8.4.9.4. Market Size and Forecast, By End User

      • 8.4.10. South Korea Animal Health Market

        • 8.4.10.1. Market Size and Forecast, By Animal Type
        • 8.4.10.2. Market Size and Forecast, By Product
        • 8.4.10.3. Market Size and Forecast, By Distribution Channel
        • 8.4.10.4. Market Size and Forecast, By End User

      • 8.4.11. Australia Animal Health Market

        • 8.4.11.1. Market Size and Forecast, By Animal Type
        • 8.4.11.2. Market Size and Forecast, By Product
        • 8.4.11.3. Market Size and Forecast, By Distribution Channel
        • 8.4.11.4. Market Size and Forecast, By End User

      • 8.4.12. Thailand Animal Health Market

        • 8.4.12.1. Market Size and Forecast, By Animal Type
        • 8.4.12.2. Market Size and Forecast, By Product
        • 8.4.12.3. Market Size and Forecast, By Distribution Channel
        • 8.4.12.4. Market Size and Forecast, By End User

      • 8.4.13. Malaysia Animal Health Market

        • 8.4.13.1. Market Size and Forecast, By Animal Type
        • 8.4.13.2. Market Size and Forecast, By Product
        • 8.4.13.3. Market Size and Forecast, By Distribution Channel
        • 8.4.13.4. Market Size and Forecast, By End User

      • 8.4.14. Indonesia Animal Health Market

        • 8.4.14.1. Market Size and Forecast, By Animal Type
        • 8.4.14.2. Market Size and Forecast, By Product
        • 8.4.14.3. Market Size and Forecast, By Distribution Channel
        • 8.4.14.4. Market Size and Forecast, By End User

      • 8.4.15. Rest of Asia Pacific Animal Health Market

        • 8.4.15.1. Market Size and Forecast, By Animal Type
        • 8.4.15.2. Market Size and Forecast, By Product
        • 8.4.15.3. Market Size and Forecast, By Distribution Channel
        • 8.4.15.4. Market Size and Forecast, By End User

    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Animal Type

      • 8.5.3. Market Size and Forecast, By Product

      • 8.5.4. Market Size and Forecast, By Distribution Channel

      • 8.5.5. Market Size and Forecast, By End User

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Animal Health Market

        • 8.5.7.1. Market Size and Forecast, By Animal Type
        • 8.5.7.2. Market Size and Forecast, By Product
        • 8.5.7.3. Market Size and Forecast, By Distribution Channel
        • 8.5.7.4. Market Size and Forecast, By End User

      • 8.5.8. South Africa Animal Health Market

        • 8.5.8.1. Market Size and Forecast, By Animal Type
        • 8.5.8.2. Market Size and Forecast, By Product
        • 8.5.8.3. Market Size and Forecast, By Distribution Channel
        • 8.5.8.4. Market Size and Forecast, By End User

      • 8.5.9. Saudi Arabia Animal Health Market

        • 8.5.9.1. Market Size and Forecast, By Animal Type
        • 8.5.9.2. Market Size and Forecast, By Product
        • 8.5.9.3. Market Size and Forecast, By Distribution Channel
        • 8.5.9.4. Market Size and Forecast, By End User

      • 8.5.10. UAE Animal Health Market

        • 8.5.10.1. Market Size and Forecast, By Animal Type
        • 8.5.10.2. Market Size and Forecast, By Product
        • 8.5.10.3. Market Size and Forecast, By Distribution Channel
        • 8.5.10.4. Market Size and Forecast, By End User

      • 8.5.11. Argentina Animal Health Market

        • 8.5.11.1. Market Size and Forecast, By Animal Type
        • 8.5.11.2. Market Size and Forecast, By Product
        • 8.5.11.3. Market Size and Forecast, By Distribution Channel
        • 8.5.11.4. Market Size and Forecast, By End User

      • 8.5.12. Rest of LAMEA Animal Health Market

        • 8.5.12.1. Market Size and Forecast, By Animal Type
        • 8.5.12.2. Market Size and Forecast, By Product
        • 8.5.12.3. Market Size and Forecast, By Distribution Channel
        • 8.5.12.4. Market Size and Forecast, By End User

  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning,2022

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Intas Pharmaceuticals Ltd.

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. Merck Animal Health

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. Bayer

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. Sanofi S.A. (MERIAL Limited)

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. Elanco (Eli Lilly And Company)

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Zydus Animal Health

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. Zoetis Inc.

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Vetoquinol

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Ceva Santé Animale

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. Virbac Group

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL HEALTH MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL ANIMAL HEALTH MARKET FOR PRODUCTION ANIMAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL ANIMAL HEALTH MARKET FOR COMPANION ANIMAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL ANIMAL HEALTH MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL ANIMAL HEALTH MARKET FOR VACCINES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL ANIMAL HEALTH MARKET FOR PHARMACEUTICAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL ANIMAL HEALTH MARKET FOR DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL ANIMAL HEALTH MARKET FOR FEED ADDITIVES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL ANIMAL HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL ANIMAL HEALTH MARKET FOR RETAIL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL ANIMAL HEALTH MARKET FOR VETERINARY HOSPITALS CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL ANIMAL HEALTH MARKET FOR E-COMMERCE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL ANIMAL HEALTH MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL ANIMAL HEALTH MARKET FOR REFERENCE LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL ANIMAL HEALTH MARKET FOR VETERINARY HOSPITALS CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL ANIMAL HEALTH MARKET FOR POINT-OF-CARE TESTING/IN-HOUSE TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL ANIMAL HEALTH MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL ANIMAL HEALTH MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA ANIMAL HEALTH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. U.S. ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 25. U.S. ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 26. U.S. ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 27. U.S. ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 28. CANADA ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 29. CANADA ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 30. CANADA ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 31. CANADA ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 32. MEXICO ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 33. MEXICO ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE ANIMAL HEALTH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 41. FRANCE ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 42. FRANCE ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 43. FRANCE ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 44. FRANCE ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. GERMANY ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 46. GERMANY ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 47. GERMANY ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 48. GERMANY ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. ITALY ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 50. ITALY ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 51. ITALY ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 52. ITALY ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 53. SPAIN ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 54. SPAIN ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 55. SPAIN ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 56. SPAIN ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 57. UK ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 58. UK ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 59. UK ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 60. UK ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. RUSSIA ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 62. RUSSIA ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 63. RUSSIA ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 64. RUSSIA ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. REST OF EUROPE ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 66. REST OF EUROPE ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 67. REST OF EUROPE ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 68. REST OF EUROPE ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 69. ASIA-PACIFIC ANIMAL HEALTH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 70. ASIA-PACIFIC ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 71. ASIA-PACIFIC ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 72. ASIA-PACIFIC ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 73. ASIA-PACIFIC ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. CHINA ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 75. CHINA ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 76. CHINA ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 77. CHINA ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. JAPAN ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 79. JAPAN ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 80. JAPAN ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 81. JAPAN ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 82. INDIA ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 83. INDIA ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 84. INDIA ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 85. INDIA ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH KOREA ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 87. SOUTH KOREA ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 88. SOUTH KOREA ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH KOREA ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. AUSTRALIA ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 91. AUSTRALIA ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 92. AUSTRALIA ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 93. AUSTRALIA ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 94. THAILAND ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 95. THAILAND ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 96. THAILAND ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 97. THAILAND ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 98. MALAYSIA ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 99. MALAYSIA ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 100. MALAYSIA ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 101. MALAYSIA ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 102. INDONESIA ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 103. INDONESIA ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 104. INDONESIA ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 105. INDONESIA ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 106. REST OF ASIA PACIFIC ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 107. REST OF ASIA PACIFIC ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 108. REST OF ASIA PACIFIC ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 109. REST OF ASIA PACIFIC ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 110. LAMEA ANIMAL HEALTH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 111. LAMEA ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 112. LAMEA ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 113. LAMEA ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 114. LAMEA ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 115. BRAZIL ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 116. BRAZIL ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 117. BRAZIL ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 118. BRAZIL ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 119. SOUTH AFRICA ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 120. SOUTH AFRICA ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 121. SOUTH AFRICA ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 122. SOUTH AFRICA ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 123. SAUDI ARABIA ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 124. SAUDI ARABIA ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 125. SAUDI ARABIA ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 126. SAUDI ARABIA ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 127. UAE ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 128. UAE ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 129. UAE ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 130. UAE ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 131. ARGENTINA ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 132. ARGENTINA ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 133. ARGENTINA ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 134. ARGENTINA ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 135. REST OF LAMEA ANIMAL HEALTH, BY ANIMAL TYPE, 2022-2032 ($MILLION)
  • TABLE 136. REST OF LAMEA ANIMAL HEALTH, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 137. REST OF LAMEA ANIMAL HEALTH, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 138. REST OF LAMEA ANIMAL HEALTH, BY END USER, 2022-2032 ($MILLION)
  • TABLE 139. INTAS PHARMACEUTICALS LTD.: KEY EXECUTIVES
  • TABLE 140. INTAS PHARMACEUTICALS LTD.: COMPANY SNAPSHOT
  • TABLE 141. INTAS PHARMACEUTICALS LTD.: OPERATING SEGMENTS
  • TABLE 142. INTAS PHARMACEUTICALS LTD.: PRODUCT PORTFOLIO
  • TABLE 143. INTAS PHARMACEUTICALS LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. MERCK ANIMAL HEALTH: KEY EXECUTIVES
  • TABLE 145. MERCK ANIMAL HEALTH: COMPANY SNAPSHOT
  • TABLE 146. MERCK ANIMAL HEALTH: OPERATING SEGMENTS
  • TABLE 147. MERCK ANIMAL HEALTH: PRODUCT PORTFOLIO
  • TABLE 148. MERCK ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. BAYER: KEY EXECUTIVES
  • TABLE 150. BAYER: COMPANY SNAPSHOT
  • TABLE 151. BAYER: OPERATING SEGMENTS
  • TABLE 152. BAYER: PRODUCT PORTFOLIO
  • TABLE 153. BAYER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154. SANOFI S.A. (MERIAL LIMITED): KEY EXECUTIVES
  • TABLE 155. SANOFI S.A. (MERIAL LIMITED): COMPANY SNAPSHOT
  • TABLE 156. SANOFI S.A. (MERIAL LIMITED): OPERATING SEGMENTS
  • TABLE 157. SANOFI S.A. (MERIAL LIMITED): PRODUCT PORTFOLIO
  • TABLE 158. SANOFI S.A. (MERIAL LIMITED): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 159. ELANCO (ELI LILLY AND COMPANY): KEY EXECUTIVES
  • TABLE 160. ELANCO (ELI LILLY AND COMPANY): COMPANY SNAPSHOT
  • TABLE 161. ELANCO (ELI LILLY AND COMPANY): OPERATING SEGMENTS
  • TABLE 162. ELANCO (ELI LILLY AND COMPANY): PRODUCT PORTFOLIO
  • TABLE 163. ELANCO (ELI LILLY AND COMPANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 164. ZYDUS ANIMAL HEALTH: KEY EXECUTIVES
  • TABLE 165. ZYDUS ANIMAL HEALTH: COMPANY SNAPSHOT
  • TABLE 166. ZYDUS ANIMAL HEALTH: OPERATING SEGMENTS
  • TABLE 167. ZYDUS ANIMAL HEALTH: PRODUCT PORTFOLIO
  • TABLE 168. ZYDUS ANIMAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 169. ZOETIS INC.: KEY EXECUTIVES
  • TABLE 170. ZOETIS INC.: COMPANY SNAPSHOT
  • TABLE 171. ZOETIS INC.: OPERATING SEGMENTS
  • TABLE 172. ZOETIS INC.: PRODUCT PORTFOLIO
  • TABLE 173. ZOETIS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 174. VETOQUINOL: KEY EXECUTIVES
  • TABLE 175. VETOQUINOL: COMPANY SNAPSHOT
  • TABLE 176. VETOQUINOL: OPERATING SEGMENTS
  • TABLE 177. VETOQUINOL: PRODUCT PORTFOLIO
  • TABLE 178. VETOQUINOL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 179. CEVA SANTé ANIMALE: KEY EXECUTIVES
  • TABLE 180. CEVA SANTé ANIMALE: COMPANY SNAPSHOT
  • TABLE 181. CEVA SANTé ANIMALE: OPERATING SEGMENTS
  • TABLE 182. CEVA SANTé ANIMALE: PRODUCT PORTFOLIO
  • TABLE 183. CEVA SANTé ANIMALE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 184. VIRBAC GROUP: KEY EXECUTIVES
  • TABLE 185. VIRBAC GROUP: COMPANY SNAPSHOT
  • TABLE 186. VIRBAC GROUP: OPERATING SEGMENTS
  • TABLE 187. VIRBAC GROUP: PRODUCT PORTFOLIO
  • TABLE 188. VIRBAC GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL HEALTH MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ANIMAL HEALTH MARKET
  • FIGURE 3. SEGMENTATION ANIMAL HEALTH MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ANIMAL HEALTH MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALANIMAL HEALTH MARKET
  • FIGURE 11. ANIMAL HEALTH MARKET SEGMENTATION, BY BY ANIMAL TYPE
  • FIGURE 12. ANIMAL HEALTH MARKET FOR PRODUCTION ANIMAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. ANIMAL HEALTH MARKET FOR COMPANION ANIMAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. ANIMAL HEALTH MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 15. ANIMAL HEALTH MARKET FOR VACCINES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. ANIMAL HEALTH MARKET FOR PHARMACEUTICAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. ANIMAL HEALTH MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. ANIMAL HEALTH MARKET FOR FEED ADDITIVES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. ANIMAL HEALTH MARKET SEGMENTATION, BY BY DISTRIBUTION CHANNEL
  • FIGURE 20. ANIMAL HEALTH MARKET FOR RETAIL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. ANIMAL HEALTH MARKET FOR VETERINARY HOSPITALS CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. ANIMAL HEALTH MARKET FOR E-COMMERCE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. ANIMAL HEALTH MARKET SEGMENTATION, BY BY END USER
  • FIGURE 24. ANIMAL HEALTH MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. ANIMAL HEALTH MARKET FOR VETERINARY HOSPITALS CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. ANIMAL HEALTH MARKET FOR POINT-OF-CARE TESTING/IN-HOUSE TESTING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. ANIMAL HEALTH MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 29. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 30. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 31. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 32. COMPETITIVE DASHBOARD
  • FIGURE 33. COMPETITIVE HEATMAP: ANIMAL HEALTH MARKET
  • FIGURE 34. Top player positioning, 2022
  • FIGURE 35. INTAS PHARMACEUTICALS LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 36. INTAS PHARMACEUTICALS LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 37. INTAS PHARMACEUTICALS LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 38. MERCK ANIMAL HEALTH: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. MERCK ANIMAL HEALTH: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. MERCK ANIMAL HEALTH: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 41. BAYER: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. BAYER: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. BAYER: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. SANOFI S.A. (MERIAL LIMITED): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. SANOFI S.A. (MERIAL LIMITED): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. SANOFI S.A. (MERIAL LIMITED): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. ELANCO (ELI LILLY AND COMPANY): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. ELANCO (ELI LILLY AND COMPANY): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. ELANCO (ELI LILLY AND COMPANY): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. ZYDUS ANIMAL HEALTH: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. ZYDUS ANIMAL HEALTH: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. ZYDUS ANIMAL HEALTH: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. ZOETIS INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. ZOETIS INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. ZOETIS INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 56. VETOQUINOL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. VETOQUINOL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 58. VETOQUINOL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 59. CEVA SANTé ANIMALE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 60. CEVA SANTé ANIMALE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 61. CEVA SANTé ANIMALE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 62. VIRBAC GROUP: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 63. VIRBAC GROUP: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 64. VIRBAC GROUP: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Animal Health Market

Start reading.
This Report and over 68,075+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers